History

VEROVACCiNES spun off Martin-Luther-University Halle-Wittenberg in 2017. After validating the novel technology platform (Proof of Concept in several vaccine programs), we are pursuing development of our product pipeline and scaling up manufacturing.

More about us

09/2022

Feasibility of production scale up

07/2018

Move to own facility

03/2018

Patents transferred from university to Verovaccines

12/2017

Seed investment round

12/2017

Filing multivalency patent

07/2017

Foundation Verovaccines GmbH

12/2014

Hugo Junkers prize

04/2014

Dr. Hennemann joins team

2009

Start research on technology